In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel ...
MedPage Today on MSN
Scandinavian Study Shreds COVID Vaccine-Myositis Link
Public health researchers found no uptick in myositis associated with COVID-19 vaccines across Norway and Sweden in a ...
Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported in the ...
Moderna said Wednesday that its experimental mRNA-based seasonal flu vaccine generated a stronger immune response against four strains of the flu virus than a currently marketed vaccine in a Phase 3 ...
SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of ...
In a recent article published in Nature Communications, researchers investigated whether messenger ribonucleic acid (mRNA) technology-based coronavirus disease 2019 (COVID-19) vaccines promote the ...
Investigators also confirmed that FGFR2 fusion–positive tumors have a higher expression of FGFR2 but were not associated with higher expression of FGFR1, FGFR3, or FGFR4. Investigators concluded that ...
Researchers discovered that embryos must clear maternal mRNAs to develop properly. When cleanup fails, it causes aberrant transcription and R-loop formation, which blocks DNA replication, damages the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback